STOCK TITAN

[SCHEDULE 13G/A] RxSight, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

Divisadero Street Capital and affiliated entities, together with William Zolezzi, report beneficial ownership of 218,918 shares of RxSight common stock, representing approximately 0.5% of the class. The filing shows no sole voting or dispositive power and reports shared voting and dispositive power over 218,918 shares, indicating coordinated control among the reporting persons rather than individual sole authority. The report states these securities are directly owned by advisory clients of Divisadero Street Capital Management and that no advisory client holds more than 5% of the class.

The filing is submitted as a Schedule 13G/A by the investment-adviser and affiliated entities and includes a joint filing agreement and an exhibit identifying the control person.

Divisadero Street Capital e soggetti affiliati, insieme a William Zolezzi, dichiarano la titolarità beneficiaria di 218,918 azioni ordinarie di RxSight, corrispondenti a circa 0.5% della classe. La segnalazione indica assenza di potere di voto o di disposizione in via esclusiva e riporta potere di voto e di disposizione condiviso su 218,918 azioni, facendo riferimento a un controllo coordinato tra i soggetti dichiarante piuttosto che a un'autorità esclusiva individuale. Il rapporto specifica che questi titoli sono detenuti direttamente da clienti cui Divisadero Street Capital Management fornisce consulenza e che nessun cliente consulito detiene più del 5% della classe.

La comunicazione è presentata come Schedule 13G/A dall'investment adviser e dalle entità affiliate e include un accordo di deposito congiunto e un allegato che identifica la persona di controllo.

Divisadero Street Capital y entidades afiliadas, junto con William Zolezzi, informan sobre la propiedad beneficiaria de 218,918 acciones ordinarias de RxSight, que representan aproximadamente el 0.5% de la clase. La presentación muestra ausencia de poder de voto o de disposición exclusivo y reporta poder de voto y de disposición compartido sobre 218,918 acciones, indicando un control coordinado entre las personas que informan en lugar de una autoridad individual exclusiva. El informe señala que estos valores son propiedad directa de clientes asesorados por Divisadero Street Capital Management y que ningún cliente asesorado posee más del 5% de la clase.

La presentación se realiza como Schedule 13G/A por el gestor de inversiones y las entidades afiliadas e incluye un acuerdo de presentación conjunta y un anexo que identifica a la persona de control.

Divisadero Street Capital 및 계열사들은 William Zolezzi와 함께 RxSight 보통주 218,918주의 실질적 소유를 보고했으며, 이는 해당 종목의 약 0.5%에 해당합니다. 제출서류는 단독 의결권 또는 처분권이 없음을 표시하고, 218,918주에 대한 공동 의결권 및 처분권을 보고하여 보고인들 간의 협조된 통제가 존재함을 나타냅니다. 보고서에는 이 증권들이 Divisadero Street Capital Management의 자문 고객이 직접 보유하고 있으며 어떤 자문 고객도 해당 종목의 5%를 초과 보유하지 않는다고 명시되어 있습니다.

이 제출서는 투자자문사와 계열사가 Schedule 13G/A로 제출한 것이며, 공동 제출 계약서와 통제자를 식별하는 부속서가 포함되어 있습니다.

Divisadero Street Capital et des entités affiliées, ainsi que William Zolezzi, déclarent la propriété bénéficiaire de 218,918 actions ordinaires de RxSight, représentant environ 0.5% de la catégorie. Le dépôt indique qu'il n'y a ni pouvoir de vote ni pouvoir de disposition exclusif et signale un pouvoir de vote et de disposition partagé sur 218,918 actions, traduisant un contrôle coordonné entre les déclarants plutôt qu'une autorité individuelle exclusive. Le rapport précise que ces titres sont détenus directement par des clients conseillés par Divisadero Street Capital Management et qu'aucun client conseillé ne détient plus de 5% de la catégorie.

La déclaration est soumise en tant que Schedule 13G/A par le gestionnaire‑conseil et les entités affiliées et comprend un accord de dépôt conjoint ainsi qu'une annexe identifiant la personne exerçant le contrôle.

Divisadero Street Capital und verbundene Einheiten geben zusammen mit William Zolezzi den wirtschaftlichen Besitz von 218,918 Aktien von RxSight an, was etwa 0.5% der Klasse entspricht. Die Einreichung weist keine alleinige Stimm- oder Verfügungsgewalt aus und meldet gemeinsame Stimm- und Verfügungsgewalt über 218,918 Aktien, was auf eine koordinierte Kontrolle der meldenden Personen statt einer individuellen Alleinbefugnis hinweist. Im Bericht heißt es, dass diese Wertpapiere unmittelbar von Beratungskunden von Divisadero Street Capital Management gehalten werden und dass kein Beratungskunde mehr als 5% der Klasse besitzt.

Die Einreichung erfolgt als Schedule 13G/A durch den Investment‑Advisor und die verbundenen Stellen und enthält eine Vereinbarung zur gemeinsamen Einreichung sowie einen Anhang, der die kontrollierende Person identifiziert.

Positive
  • None.
Negative
  • None.

Insights

TL;DR Small, passive 0.5% position by Divisadero Street; unlikely to affect RxSight's control or near-term valuation.

The filing discloses 218,918 shares (≈0.5%) held with shared voting and dispositive authority and 0 shares held with sole authority. Because the holdings are directly owned by advisory clients and each client is stated not to hold more than 5%, this appears to be a routine disclosure of a passive investment position rather than an activist or controlling stake. For investors, the filing signals transparency about ownership structure but does not indicate material governance influence or a shift in control.

TL;DR Joint filing shows coordinated reporting and shared power, but the sub-5% stake limits formal governance influence.

The schedule identifies multiple affiliated reporting persons and records shared voting and dispositive power over the same block of 218,918 shares. The presence of a joint filing agreement and a control-person identification exhibit is standard where related entities coordinate. Because the position is below the 5% ownership threshold and the filing expressly states the securities are held for advisory clients, the legal and governance implication is limited: disclosure is required and provided, but no material change to board-level influence is indicated.

Divisadero Street Capital e soggetti affiliati, insieme a William Zolezzi, dichiarano la titolarità beneficiaria di 218,918 azioni ordinarie di RxSight, corrispondenti a circa 0.5% della classe. La segnalazione indica assenza di potere di voto o di disposizione in via esclusiva e riporta potere di voto e di disposizione condiviso su 218,918 azioni, facendo riferimento a un controllo coordinato tra i soggetti dichiarante piuttosto che a un'autorità esclusiva individuale. Il rapporto specifica che questi titoli sono detenuti direttamente da clienti cui Divisadero Street Capital Management fornisce consulenza e che nessun cliente consulito detiene più del 5% della classe.

La comunicazione è presentata come Schedule 13G/A dall'investment adviser e dalle entità affiliate e include un accordo di deposito congiunto e un allegato che identifica la persona di controllo.

Divisadero Street Capital y entidades afiliadas, junto con William Zolezzi, informan sobre la propiedad beneficiaria de 218,918 acciones ordinarias de RxSight, que representan aproximadamente el 0.5% de la clase. La presentación muestra ausencia de poder de voto o de disposición exclusivo y reporta poder de voto y de disposición compartido sobre 218,918 acciones, indicando un control coordinado entre las personas que informan en lugar de una autoridad individual exclusiva. El informe señala que estos valores son propiedad directa de clientes asesorados por Divisadero Street Capital Management y que ningún cliente asesorado posee más del 5% de la clase.

La presentación se realiza como Schedule 13G/A por el gestor de inversiones y las entidades afiliadas e incluye un acuerdo de presentación conjunta y un anexo que identifica a la persona de control.

Divisadero Street Capital 및 계열사들은 William Zolezzi와 함께 RxSight 보통주 218,918주의 실질적 소유를 보고했으며, 이는 해당 종목의 약 0.5%에 해당합니다. 제출서류는 단독 의결권 또는 처분권이 없음을 표시하고, 218,918주에 대한 공동 의결권 및 처분권을 보고하여 보고인들 간의 협조된 통제가 존재함을 나타냅니다. 보고서에는 이 증권들이 Divisadero Street Capital Management의 자문 고객이 직접 보유하고 있으며 어떤 자문 고객도 해당 종목의 5%를 초과 보유하지 않는다고 명시되어 있습니다.

이 제출서는 투자자문사와 계열사가 Schedule 13G/A로 제출한 것이며, 공동 제출 계약서와 통제자를 식별하는 부속서가 포함되어 있습니다.

Divisadero Street Capital et des entités affiliées, ainsi que William Zolezzi, déclarent la propriété bénéficiaire de 218,918 actions ordinaires de RxSight, représentant environ 0.5% de la catégorie. Le dépôt indique qu'il n'y a ni pouvoir de vote ni pouvoir de disposition exclusif et signale un pouvoir de vote et de disposition partagé sur 218,918 actions, traduisant un contrôle coordonné entre les déclarants plutôt qu'une autorité individuelle exclusive. Le rapport précise que ces titres sont détenus directement par des clients conseillés par Divisadero Street Capital Management et qu'aucun client conseillé ne détient plus de 5% de la catégorie.

La déclaration est soumise en tant que Schedule 13G/A par le gestionnaire‑conseil et les entités affiliées et comprend un accord de dépôt conjoint ainsi qu'une annexe identifiant la personne exerçant le contrôle.

Divisadero Street Capital und verbundene Einheiten geben zusammen mit William Zolezzi den wirtschaftlichen Besitz von 218,918 Aktien von RxSight an, was etwa 0.5% der Klasse entspricht. Die Einreichung weist keine alleinige Stimm- oder Verfügungsgewalt aus und meldet gemeinsame Stimm- und Verfügungsgewalt über 218,918 Aktien, was auf eine koordinierte Kontrolle der meldenden Personen statt einer individuellen Alleinbefugnis hinweist. Im Bericht heißt es, dass diese Wertpapiere unmittelbar von Beratungskunden von Divisadero Street Capital Management gehalten werden und dass kein Beratungskunde mehr als 5% der Klasse besitzt.

Die Einreichung erfolgt als Schedule 13G/A durch den Investment‑Advisor und die verbundenen Stellen und enthält eine Vereinbarung zur gemeinsamen Einreichung sowie einen Anhang, der die kontrollierende Person identifiziert.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Divisadero Street Capital Management, LP
Signature:/s/ William Zolezzi
Name/Title:William Zolezzi/Manager
Date:08/13/2025
William Zolezzi
Signature:/s/ William Zolezzi
Name/Title:William Zolezzi/Manager
Date:08/13/2025
Divisadero Street Partners, L.P.
Signature:/s/ William Zolezzi
Name/Title:William Zolezzi/Manager
Date:08/13/2025
Divisadero Street Partners GP, LLC
Signature:/s/ William Zolezzi
Name/Title:William Zolezzi/Manager
Date:08/13/2025
Divisadero Street Capital, LLC
Signature:/s/ William Zolezzi
Name/Title:William Zolezzi/Manager
Date:08/13/2025

Comments accompanying signature: * Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. To the extent that "ownership of 5 percent or less of a class" was indicated in Item 5, such response only applies to the Reporting Person(s) that indicated elsewhere herein that it beneficially owns five percent (5%) or less of the class.
Exhibit Information

[Exhibit A - Joint Filing Agreement] [Exhibit B - Control Person Identification]

FAQ

Who filed the Schedule 13G/A for RxSight (RXST)?

The filing was submitted by Divisadero Street Capital Management, LP; William Zolezzi; Divisadero Street Partners, L.P.; Divisadero Street Partners GP, LLC; and Divisadero Street Capital, LLC.

How many RxSight shares does Divisadero Street report owning and what percent is that?

The reporting persons disclose beneficial ownership of 218,918 shares, representing approximately 0.5% of RxSight's common stock.

Does the filer have sole voting or dispositive power over the reported shares?

No. The filing reports 0 shares with sole voting or dispositive power and 218,918 shares with shared voting and dispositive power.

Are the reported shares held on behalf of other persons?

Yes. The filing states the securities are directly owned by advisory clients of Divisadero Street Capital Management, LP, and none of those advisory clients owns more than 5% of the class.

What exhibits accompany the Schedule 13G/A filing?

The filing references Exhibit A - Joint Filing Agreement and Exhibit B - Control Person Identification.
Rxsight, Inc.

NASDAQ:RXST

RXST Rankings

RXST Latest News

RXST Latest SEC Filings

RXST Stock Data

300.73M
38.41M
5.52%
98.89%
12.2%
Medical Devices
Ophthalmic Goods
Link
United States
ALISO VIEJO